R&D Systems™ Recombinant Human IMP Dehydrogenase 2/IMPDH2 Protein

Catalog No.	Quantity
83-49D-H050	50 μg

Catalog No. 83-49D-H050 Supplier R&D Systems™ Supplier No. 8349DH050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IMP Dehydrogenase 2/IMPDH2 Protein is derived from Sf 21 (baculovirus). The Recombinant Human IMP Dehydrogenase 2/IMPDH2 Protein has been validated for the following applications: Enzyme Activity.

Specifications

• Accession Number: P12268
• For Use With (Application): Enzyme Activity
• Formulation: Supplied as a 0.2 μm filtered solution in Tris, NaCl, DTT and Glycerol.
• Gene ID (Entrez): 3615
• Molecular Weight (g/mol): 57 kDa
• Quantity: 50 μg
• Source: <EM>Spodoptera frμgiperda</EM>, <EM>Sf</EM> 21 (baculovirus)-derived human IMP Dehydrogenase 2/IMPDH2 protein Met1-Phe514, with a C-terminal 10-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles; 6 months from date of receipt, -20 to -70°C as supplied; 3 months, -20 to -70°C under sterile conditions after opening.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Cross Reactivity: IMP Dehydrogenase 2/IMPDH2
• Species: Human
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.